GORMAN KEVIN CHARLES

PrivateCIK: 1201096
Location

SAN DIEGO, CA

GORMAN KEVIN CHARLES (Chief Executive Officer) received a stock award from NEUROCRINE BIOSCIENCES INC

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderGORMAN KEVIN CHARLESCIK 1201096
DirectorOfficer· Chief Executive Officer
Since Feb 2019
+23.42K
Net shares
Net buyer
$5.00M
Total sold
0
Open market trades
0B · 0S
8
Total transactions
74.70K acquired · 51.29K disposed
Non-Derivative Transactions6

Common Stock

Direct
M · Option Exercise

Shares

+5.60K

Price / share

Trade value

% of position

1.1%
2/13/2026
516.89K522.50K

Common Stock

Direct
F · Tax Withholding

Shares

3.02K

Price / share

$124.12

Trade value

$375.34K

% of position

0.6%
2/13/2026
522.50K519.47K

Common Stock

Direct
M · Option Exercise

Shares

+5.38K

Price / share

Trade value

% of position

1.0%
2/13/2026
519.47K524.85K

Common Stock

Direct
F · Tax Withholding

Shares

2.90K

Price / share

$124.12

Trade value

$360.07K

% of position

0.6%
2/13/2026
524.85K521.95K

Common Stock

Direct
A · Award

Shares

+63.72K

Price / share

Trade value

% of position

12.2%
2/13/2026
521.95K585.67K

Common Stock

Direct
F · Tax Withholding

Shares

34.38K

Price / share

$124.12

Trade value

$4.27M

% of position

5.9%
2/13/2026
585.67K551.29K
Total

Net shares

+34.40K

Net value

-$5M

Derivative Transactions2

Restricted Stock Unit

Direct
M · Option Exercise
Converts to

Common Stock

5.60K shares

Shares

5.60K

Strike price

Held after

11.21K

Exercisable

2/13/2026

Restricted Stock Unit

Direct
M · Option Exercise
Converts to

Common Stock

5.38K shares

Shares

5.38K

Strike price

Held after

5.38K

Exercisable

2/13/2026
GORMAN KEVIN CHARLES — Insider Transaction (Form 4) Filed Feb 17, 2026 | Finecho